Functional Tissue Derivatives Derived from Human Pluripotent Stem Cells provide Innovative Opportunities for Stem Cell Science

Scientists are building living human skin in the lab from stem cells, then deliberately adding immune cells to make it behave more like real tissue. This matters because current lab-grown skin models are too simple. They lack the immune cells that drive inflammation, scarring, and many skin diseases. Without those cells, researchers cannot accurately study conditions such as dystrophic epidermolysis bullosa—a severe blistering disorder—or scleroderma, nor can they reliably test new treatments. The project fills a gap between basic stem cell science and clinically useful tissue models. If successful, the work will produce a more realistic human skin platform that carries patient-specific genetic mutations. Researchers could then watch how a disease unfolds at the cellular level and test potential drugs on the same genetic background. This could reduce reliance on animal testing and speed up the development of therapies for chronic skin conditions. The models might also be used to study wound healing, infection, and inflammatory responses in a controlled, human-relevant system.